| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.046 | 0.4 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.16 | 0.4 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.4 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.4 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | 0.17 | 0.4 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | 0.033 | 0.4 |